院内感染の市場規模、シェア、成長分析：タイプ別、治療法別、感染タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

院内感染の世界市場規模は2023年に304億米ドルと評価され、予測期間（2025-2032年）のCAGRは1.5%で、2024年の308億6,000万米ドルから2032年には347億6,000万米ドルに成長する見通しです。

感染管理市場は、院内感染（HAI）に対する意識の高まり、交差感染対策への緊急のニーズ、ヘルスケア施設内での感染症流行の高まりなどを背景に力強い成長を遂げています。滅菌装置、洗浄・消毒剤、保護バリア、内視鏡再処理ツールなどの主要製品は、院内感染を最小化する上で重要な役割を果たしています。さらに、感染管理対策の改善を提唱する政府の支援イニシアティブが、この分野をさらに強化しています。病院、地域、国家レベルでの包括的な感染防止ガイドラインの採用、モニタリング技術の統合の進展は、市場拡大を後押しする重要な要因です。意識とコンプライアンスが高まるにつれて、効果的な感染管理製品およびサービスに対する需要も増加の一途をたどっており、この分野はダイナミックで重要な市場となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

院内感染市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 装置
  • 滅菌装置
  • 消毒装置
• 消耗品
  • 消毒剤
  • 滅菌消耗品
  • その他
• サービス

院内感染市場規模：治療法別& CAGR（2025-2032）

• 市場概要
• 抗菌
• 抗ウィルス薬
• 抗真菌
• その他

院内感染市場規模：感染タイプ別& CAGR（2025-2032）

• 市場概要
• 血流感染症
• 人工呼吸器関連肺炎（VAP）
• 尿路感染症
• 手術部位感染
• 胃腸感染症
• その他

院内感染市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院・クリニック
• 外来手術センター
• その他

院内感染市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• STERIS plc（Ireland）
• Getinge AB（Sweden）
• 3M（USA）
• Ecolab Inc.（USA）
• Diversey Holdings, Ltd.（USA）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• bioMerieux S.A.（France）
• Thermo Fisher Scientific Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Pfizer Inc.（USA）
• Merck & Co., Inc.（USA）
• Novartis AG（Switzerland）
• GlaxoSmithKline plc（UK）
• Sanofi S.A.（France）
• Medtronic plc（Ireland）
• Cardinal Health（USA）
• Johnson & Johnson（USA）

結論と推奨事項

Global Hospital-Acquired Infections Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 30.86 billion in 2024 to USD 34.76 billion by 2032, growing at a CAGR of 1.5% during the forecast period (2025-2032).

The infection control market is witnessing robust growth driven by heightened awareness of Hospital Acquired Infections (HAIs), the urgent need to combat cross infections, and the rising prevalence of infectious diseases within healthcare facilities. Key products such as sterilization equipment, cleaning and disinfection agents, protective barriers, and endoscope reprocessing tools play crucial roles in minimizing hospital-acquired infections. Additionally, supportive government initiatives advocating for improved infection control measures further bolster this sector. The adoption of comprehensive infection prevention guidelines at hospital, regional, and national levels, along with the growing integration of monitoring technologies, are significant factors fueling market expansion. As awareness and compliance grow, the demand for effective infection control products and services continues to rise, making this a dynamic and vital market space.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hospital-Acquired Infections market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hospital-Acquired Infections Market Segmental Analysis

Global Hospital-Acquired Infections Market is segmented by Type, Treatment, Infection Type, End User and region. Based on Type, the market is segmented into Equipment, Consumables and Services. Based on Treatment, the market is segmented into Antibacterial, Antiviral, Antifungal and Others. Based on Infection Type, the market is segmented into Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection, Gastrointestinal Infections and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hospital-Acquired Infections Market

The Global Hospital-Acquired Infections market is poised for growth driven by the rising number of surgical procedures performed globally. According to the World Health Organization, approximately 235 million major surgeries are carried out annually, a trend fueled by the increasing prevalence of obesity, lifestyle-related diseases, an aging population, and a surge in spine and sports injuries. As more surgeries take place, the demand for surgical tools and medical devices escalates. The recognized advantages of sterilized equipment, coupled with heightened awareness of their importance in healthcare environments, are expected to significantly boost the demand for services addressing hospital-acquired infections.

Restraints in the Global Hospital-Acquired Infections Market

The growth of the Global Hospital-Acquired Infections market is hindered by apprehensions surrounding the safety of reprocessed medical instruments. While reusing devices like surgical forceps, endoscopes, and stethoscopes can significantly reduce costs and environmental waste for healthcare providers, doubts persist regarding the efficacy and cleanliness of these reprocessed items. Improper cleaning and sterilization processes might leave behind blood, tissue, and other biological residue, elevating the risk of surgical-site infections (SSIs) and hospital-acquired infections (HAIs). Furthermore, any residual materials, such as chemical disinfectants, could lead to tissue irritation. This uncertainty is resulting in limited acceptance of device reprocessing among hospital administrators and clinicians.

Market Trends of the Global Hospital-Acquired Infections Market

The Global Hospital-Acquired Infections (HAIs) market is experiencing significant growth, propelled by a surge in chronic diseases like diabetes, cardiovascular disorders, and gastrointestinal conditions. With environmental and lifestyle factors contributing to rising disease prevalence-projected to escalate from 537 million diabetics in 2021 to approximately 783 million by 2045-there will be an uptick in surgical procedures, consequently elevating the risk of HAIs. Increased awareness and need for stringent sterilization and disinfection protocols will further drive demand for infection control devices. As such, the market is poised for robust expansion, addressing both the rise in surgical interventions and the necessity for enhanced infection prevention measures.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infections Market Size by Type & CAGR (2025-2032)

• Market Overview
• Equipment
  • Sterilization Equipment
  • Disinfection Equipment
• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others
• Services

Global Hospital-Acquired Infections Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Antibacterial
• Antiviral
• Antifungal
• Others

Global Hospital-Acquired Infections Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Bloodstream Infections
• Ventilator-Associated Pneumonia (VAP)
• Urinary Tract Infection
• Surgical-Site Infection
• Gastrointestinal Infections
• Others

Global Hospital-Acquired Infections Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Global Hospital-Acquired Infections Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Infection Type, End User)
  • US
  • Canada
• Europe (Type, Treatment, Infection Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Infection Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Infection Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Infection Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• STERIS plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diversey Holdings, Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations